glp 1 etf Eli Lilly, GLP-1 Troubles Are Dragging Down This Healthcare OZEM, Weight Loss Drug ETFs:

All information is based on publicly available sources as of November 2025

For all these effects, different benefits have been attributed to DPP-4is (including improvement of oxidative stress, inflammation, fibrosis and apoptosis, endothelial function, and tissue reparation), related to renal protection and a variety of cardiovascular and metabolic clinical conditions beyond T2D, including hypertension, calcified aortic valve disease, atherosclerosis, and heart failure (HF) [47,68]

Side Effects and Future Treatment More participants in the orforglipron groups discontinued study treatment due to adverse events than in the semaglutide groups

A once-a-day pill that you can make part of your existing medication routine could, in theory, make it easier for patients to stay on a GLP-1 if thats appropriate or necessary

Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers